Quest Diagnostics Total Long Term Liabilities 2010-2024 | DGX

Quest Diagnostics total long term liabilities for the quarter ending September 30, 2024 were $7.162B, a 32.61% increase year-over-year.

  • Quest Diagnostics total long term liabilities for 2023 were $5.865B, a 9.5% increase from 2022.
  • Quest Diagnostics total long term liabilities for 2022 were $5.356B, a 0.35% decline from 2021.
  • Quest Diagnostics total long term liabilities for 2021 were $5.375B, a 1.21% decline from 2020.

Quest Diagnostics Total Long Term Liabilities 2010-2024 | DGX

  • Quest Diagnostics total long term liabilities for 2023 were $5.865B, a 9.5% increase from 2022.
  • Quest Diagnostics total long term liabilities for 2022 were $5.356B, a 0.35% decline from 2021.
  • Quest Diagnostics total long term liabilities for 2021 were $5.375B, a 1.21% decline from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.4B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$7B
RadNet (RDNT)$5.4B
Option Care Health (OPCH)$3.8B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.8B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$237M
Daxor (DXR)$46M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$11M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M